Insider · CIK 0001286102
Harry J Leonhardt
Files at PSTX (Poseida Therapeutics, Inc.). First filing -, latest -.
Harry J Leonhardt files SEC Form 4 as officer at PSTX (Poseida Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Harry J Leonhardt has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | UTender of shares Common Stock | -223,640 | - | - | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -160,385 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -137,000 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -72,568 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -125,283 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -111,700 | $0.00 | $0 | 0 | Jan 8, 2025 |
Questions about Harry J Leonhardt
Answered from the filings on this page, as of the latest one.
Is Harry J Leonhardt buying or selling?
Harry J Leonhardt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Harry J Leonhardt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Harry J Leonhardt has 0.
Where does Harry J Leonhardt file Form 4?
Harry J Leonhardt has filed Form 4 at PSTX (Poseida Therapeutics, Inc.) as GC & Chief Compliance Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.